Search Close Search
Search Close Search


The mission of the UMass Memorial Health and UMass Chan Medical School Rheumatology Inflammatory Arthritis Program is to provide the highest quality of care to patients with inflammatory arthritis by pioneering digital solutions to transform the way we diagnose, treat, and monitor arthritis, putting patients at the center of care.

It is our vision to become a global leader in inflammatory arthritis by implementing innovative, patient-centered care algorithms, setting a benchmark for others in this field.


Learn more and schedule an appointment

Page Menu

Pioneering Digital Solutions for Arthritis

Early Diagnosis

Our team prioritizes early identification of arthritis to ensure prompt and effective treatment, leading to better long-term outcomes for patients.

Novel Care Models

We're implementing innovative patient care approaches that leverage digital tools to enhance engagement, monitoring, and personalized care.


Meet the Directors

Karen Salomon-Escoto, MD

Karen Salomon-Escoto, MD

Dr. Salomon-Escoto is a clinician-researcher specializing in rheumatoid, with deep expertise in patient-centered, technology-driven care. As the founding director of the UMass Rheumatology Musculoskeletal Ultrasound Program and the new Inflammatory Arthritis Program, Dr. Salomon-Escoto focuses on leveraging digital tools to enhance patient engagement, streamline patient identification, and advance remote monitoring models. Her current work centers on improving clinical outcomes through continuous, personalized care supported by digital health technologies, while scaling these approaches to broaden patient access and impact. Through this program, Dr. Salomon-Escoto aims to drive innovation and efficiency in inflammatory arthritis management, ensuring timely, high-quality care and contributing to the field through rigorous, evidence-based research.

Jonathan Kay, MD

Jonathan Kay, MD

Dr. Kay is a distinguished rheumatologist renowned for his expertise in inflammatory arthritis, medical education, and leadership in innovative research. With a deep commitment to advancing the understanding and treatment of inflammatory arthritis, Dr. Kay has contributed significantly to the field through clinical care and research initiatives. As a co-director of the Inflammatory Arthritis Program in the Division of Rheumatology at UMass, he plays a pivotal role in shaping cutting-edge approaches to patient care and improving clinical outcomes. In addition to his clinical work, Dr. Kay is dedicated to educating the next generation of rheumatologists and advancing research that informs best practices in the management of inflammatory arthritis. His leadership continues to drive forward innovation in both patient care and academic research.

Meet Our Collaborators and Specialists

Zheni Stavre, MD

Zheni Stavre, MD

Psoriatic Arthritis Clinic Director

Dr. Stavre pioneered the UMass Rheumatology Psoriatic Arthritis clinic, specializing in early diagnosis and treatment of this condition. Her focused approach ensures patients receive timely, effective care from the earliest stages of their condition. Her expertise includes implementing innovative treatment protocols and developing comprehensive care strategies that address both the joint and skin manifestations of psoriatic arthritis. She collaborates closely with Dermatology to provide integrated care for optimal patient outcomes.

Yevgeniy Popov, DO, MPH

Yevgeniy (Eugene) Popov, DO, MPH

Clinical Informatics

A key member of the patient-care team and Epic systems specialist, Dr. Popov combines clinical expertise with technical innovation. As an Epic builder, he develops digital tools that enhance patient data tracking and improve care delivery efficiency.  His work focuses on streamlining clinical workflows, implementing decision support systems, and creating custom solutions that enable better patient monitoring and outcomes analysis. Dr. Popov's unique blend of medical knowledge and technical expertise has been instrumental in advancing digital health initiatives and improving the quality of patient care.

James Fournier, CNP

James Fournier, CNP

Clinician and Clinical Trials Joint Assessor

James Fournier plays a vital role in providing comprehensive care to inflammatory arthritis patients. His expertise in clinical care, combined with his collaborative disposition, contributes to advancing arthritis care through clinical trials as well. Through his dedication to patient-centered care and his involvement in clinical research, James is helping to elevate the standard of care and drive progress in this important area of healthcare.


Meet the Fast Track Arthritis Team


Dr. Ratnesh Chopra, Dr. Jonathan Kay, Dr. Yevgeniy (Eugene) Popov, Dr. William Traverse, Dr. Karen Salomon-Escoto, and Dr. Peggy WuOur Fast Track Arthritis service offers designated new-patient appointments to ensure that people with joint pain at higher risk for inflammatory arthritis are seen without delay. This rapid-access clinic is staffed by a dedicated team of six rheumatologists, Dr. Ratnesh Chopra, Dr. Jonathan Kay, Dr. Yevgeniy (Eugene) Popov, Dr. William Traverse, Dr. Karen Salomon-Escoto, and Dr. Peggy Wu, working together to deliver timely evaluations, early diagnosis, and personalized treatment plans.

Our mission is simple: faster access, expert care, and a clearer path forward for every patient.







Prioritizing Early Diagnosis

Image of a patient holding their own hand

Rapid Identification

Our team uses the latest diagnostic tools to quickly identify the onset of arthritis, enabling prompt intervention.

Personalized Treatment

We develop tailored treatment plans to address each patient's unique condition and needs, maximizing effectiveness.

Preventing Progression

Early diagnosis and proactive management are key to slowing the progression of inflammatory arthritis and preserving joint function.


Novel Patient Care Models

Image of a laptopRemote Monitoring

Our platform enables continuous tracking of patient symptoms and outcomes, allowing for timely adjustments to care plans.

Image of two thought bubblesTelehealth Visits

Convenient virtual consultations with our rheumatologists ensure seamless access to care, reducing barriers to treatment.

Image of three silhouettesPatient Engagement

Interactive digital tools empower patients to actively participate in their care, fostering better outcomes.


Leveraging Digital Technology

Improving Patient Capture

Our program uses advanced digital strategies to identify and connect with more individuals living with arthritis, ensuring they receive the care they need.

Data-Driven Decisions

By continuously analyzing patient data, we can optimize treatment plans, allocate resources effectively, and drive continuous improvements in care.


Remote Patient Monitoring Platform

Image of a physician using a hand-held tablet and a laptop recording patient data

Symptom Tracking

Patients use wearable devices and mobile apps to regularly report on their arthritis symptoms and joint status.

Data Analysis

Our AI-powered platform analyzes the data to detect patterns and identify potential flare-ups or changes in condition.

Timely Interventions

Our team can then proactively adjust treatment plans and provide personalized guidance to patients, improving outcomes.


Point-of-Care Ultrasound Services

A physician giving an ultrasound to a patient

Advanced Diagnostic Capabilities

Our state-of-the-art ultrasound technology enables real-time visualization of joint inflammation and structural changes, allowing for immediate diagnosis and treatment decisions. This non-invasive imaging technique provides a detailed assessment of soft tissues, helping identify early signs of arthritis before they become visible on traditional X-rays.

Clinical Benefits

  • Immediate bedside assessment during consultation
  • Precise guidance for therapeutic joint injections
  • Real-time monitoring of treatment response
  • Enhanced patient education through visual demonstration

By integrating point-of-care ultrasound into our practice, we've significantly improved our ability to detect early disease activity and optimize treatment strategies, leading to better outcomes for our patients with inflammatory arthritis.



Integrated Specialty Pharmacy: Your Partner in Treatment Success

UMass Memorial Specialty PharmacyOur Integrated Specialty Pharmacy is an essential part of our Inflammatory Arthritis Program, offering a seamless, patient-focused experience from day one. With a dedicated, all-star team of Certified Pharmacy Technicians (CPhTs) and PharmDs, we provide unparalleled support in treatment initiation and ongoing care.



Fast, Efficient Treatment Start

When a new medication is prescribed, timing is critical. Our specialty pharmacy partners excel in getting you started on your new treatment plan faster than ever before, with a record-breaking initiation time. This means less waiting and more action toward managing your condition.

Personalized Support Every Step of the Way

We’re committed to your well-being, which is why our pharmacy team is with you throughout your treatment journey. From navigating insurance and copay assistance to managing side effects and drug adherence, our pharmacists offer frequent touchpoints to ensure you’re fully supported.

Tracking and Improving Outcomes

Our pharmacy team doesn't just dispense medications—they’re a key part of tracking your progress. Through regular follow-ups, they help monitor your response to treatment, providing insights and adjustments to help achieve the best possible outcomes.

RA Clinic Metrics

*All metrics represent FY25, October 2024 - September 2025

Prior authorizations, 4,422 PAs completed, 1.3 days, average turnaround time vs. 7-10 day industry average, Financial Assistance, 733 FAs completed, $8.3M in FA secured, Time to Therapy, 88% of prior authorizations completed within 2 days, 70% of financial assistance completed within 2 days, 2,500+ hours saved for administrative and clinical staff


Research & Clinical Trials

A scientist doing researchNovel Therapeutic Studies

Leading groundbreaking clinical trials investigating targeted biologics and innovative cellular therapies for rheumatoid and psoriatic arthritis.

Collaborative Research Network

Participating in multi-center trials through partnerships with leading research institutions and pharmaceutical companies, to accelerate therapeutic discoveries.

Our research program maintains the highest standards of scientific rigor and patient safety, with all trials conducted under strict regulatory oversight and ethical guidelines. Patients interested in participating in clinical trials can contact our research coordinator for more information about current enrollment opportunities.

Rheumatology Clinical Research Unit


Aligning with UMass Strategic Goals

Advancing Research, Our program's digital solutions will generate valuable data to support UMass Chan Medical School's leading research initiatives in rheumatology and inflammatory diseases. Enhancing Education, By integrating our innovative care models into the UMass curriculum, we will train the next generation of rheumatologists to deliver exceptional, technology-enabled care. Improving Community Health, Our focus on early diagnosis, proactive management, and digital tools will help improve outcomes and quality of life for arthritis patients across our communities.


Elevating the Standard of Arthritis Care

1, Personalized Care, tailored treatment plans, 2, Continuous Monitoring, Remote tracking of symptoms, 3, Early Intervention, Rapid diagnosis and management

By seamlessly integrating cutting-edge digital technologies, our program is transforming the standard of arthritis care, empowering patients and delivering exceptional outcomes.